Gag-protease coevolution analyses define novel structural surfaces in the HIV-1 matrix and capsid involved in resistance to Protease Inhibitors

Abstract Despite the major role of Gag in establishing resistance of HIV-1 to protease inhibitors (PIs), very limited data are available on the total contribution of Gag residues to resistance to PIs. To identify in detail Gag residues and structural interfaces associated with the development of HIV...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Francisco M Codoñer, Ruth Peña, Oscar Blanch-Lombarte, Esther Jimenez-Moyano, Maria Pino, Thomas Vollbrecht, Bonaventura Clotet, Javier Martinez-Picado, Rika Draenert, Julia G. Prado
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/cda11a62772548c99100bd0b48f86fd4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cda11a62772548c99100bd0b48f86fd4
record_format dspace
spelling oai:doaj.org-article:cda11a62772548c99100bd0b48f86fd42021-12-02T16:08:13ZGag-protease coevolution analyses define novel structural surfaces in the HIV-1 matrix and capsid involved in resistance to Protease Inhibitors10.1038/s41598-017-03260-42045-2322https://doaj.org/article/cda11a62772548c99100bd0b48f86fd42017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03260-4https://doaj.org/toc/2045-2322Abstract Despite the major role of Gag in establishing resistance of HIV-1 to protease inhibitors (PIs), very limited data are available on the total contribution of Gag residues to resistance to PIs. To identify in detail Gag residues and structural interfaces associated with the development of HIV-1 resistance to PIs, we traced viral evolution under the pressure of PIs using Gag-protease single genome sequencing and coevolution analysis of protein sequences in 4 patients treated with PIs over a 9-year period. We identified a total of 38 Gag residues correlated with the protease, 32 of which were outside Gag cleavage sites. These residues were distributed in 23 Gag-protease groups of coevolution, with the viral matrix and the capsid represented in 87% and 52% of the groups. In addition, we uncovered the distribution of Gag correlated residues in specific protein surfaces of the inner face of the viral matrix and at the Cyclophilin A binding loop of the capsid. In summary, our findings suggest a tight interdependency between Gag structural proteins and the protease during the development of resistance of HIV-1 to PIs.Francisco M CodoñerRuth PeñaOscar Blanch-LombarteEsther Jimenez-MoyanoMaria PinoThomas VollbrechtBonaventura ClotetJavier Martinez-PicadoRika DraenertJulia G. PradoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Francisco M Codoñer
Ruth Peña
Oscar Blanch-Lombarte
Esther Jimenez-Moyano
Maria Pino
Thomas Vollbrecht
Bonaventura Clotet
Javier Martinez-Picado
Rika Draenert
Julia G. Prado
Gag-protease coevolution analyses define novel structural surfaces in the HIV-1 matrix and capsid involved in resistance to Protease Inhibitors
description Abstract Despite the major role of Gag in establishing resistance of HIV-1 to protease inhibitors (PIs), very limited data are available on the total contribution of Gag residues to resistance to PIs. To identify in detail Gag residues and structural interfaces associated with the development of HIV-1 resistance to PIs, we traced viral evolution under the pressure of PIs using Gag-protease single genome sequencing and coevolution analysis of protein sequences in 4 patients treated with PIs over a 9-year period. We identified a total of 38 Gag residues correlated with the protease, 32 of which were outside Gag cleavage sites. These residues were distributed in 23 Gag-protease groups of coevolution, with the viral matrix and the capsid represented in 87% and 52% of the groups. In addition, we uncovered the distribution of Gag correlated residues in specific protein surfaces of the inner face of the viral matrix and at the Cyclophilin A binding loop of the capsid. In summary, our findings suggest a tight interdependency between Gag structural proteins and the protease during the development of resistance of HIV-1 to PIs.
format article
author Francisco M Codoñer
Ruth Peña
Oscar Blanch-Lombarte
Esther Jimenez-Moyano
Maria Pino
Thomas Vollbrecht
Bonaventura Clotet
Javier Martinez-Picado
Rika Draenert
Julia G. Prado
author_facet Francisco M Codoñer
Ruth Peña
Oscar Blanch-Lombarte
Esther Jimenez-Moyano
Maria Pino
Thomas Vollbrecht
Bonaventura Clotet
Javier Martinez-Picado
Rika Draenert
Julia G. Prado
author_sort Francisco M Codoñer
title Gag-protease coevolution analyses define novel structural surfaces in the HIV-1 matrix and capsid involved in resistance to Protease Inhibitors
title_short Gag-protease coevolution analyses define novel structural surfaces in the HIV-1 matrix and capsid involved in resistance to Protease Inhibitors
title_full Gag-protease coevolution analyses define novel structural surfaces in the HIV-1 matrix and capsid involved in resistance to Protease Inhibitors
title_fullStr Gag-protease coevolution analyses define novel structural surfaces in the HIV-1 matrix and capsid involved in resistance to Protease Inhibitors
title_full_unstemmed Gag-protease coevolution analyses define novel structural surfaces in the HIV-1 matrix and capsid involved in resistance to Protease Inhibitors
title_sort gag-protease coevolution analyses define novel structural surfaces in the hiv-1 matrix and capsid involved in resistance to protease inhibitors
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/cda11a62772548c99100bd0b48f86fd4
work_keys_str_mv AT franciscomcodoner gagproteasecoevolutionanalysesdefinenovelstructuralsurfacesinthehiv1matrixandcapsidinvolvedinresistancetoproteaseinhibitors
AT ruthpena gagproteasecoevolutionanalysesdefinenovelstructuralsurfacesinthehiv1matrixandcapsidinvolvedinresistancetoproteaseinhibitors
AT oscarblanchlombarte gagproteasecoevolutionanalysesdefinenovelstructuralsurfacesinthehiv1matrixandcapsidinvolvedinresistancetoproteaseinhibitors
AT estherjimenezmoyano gagproteasecoevolutionanalysesdefinenovelstructuralsurfacesinthehiv1matrixandcapsidinvolvedinresistancetoproteaseinhibitors
AT mariapino gagproteasecoevolutionanalysesdefinenovelstructuralsurfacesinthehiv1matrixandcapsidinvolvedinresistancetoproteaseinhibitors
AT thomasvollbrecht gagproteasecoevolutionanalysesdefinenovelstructuralsurfacesinthehiv1matrixandcapsidinvolvedinresistancetoproteaseinhibitors
AT bonaventuraclotet gagproteasecoevolutionanalysesdefinenovelstructuralsurfacesinthehiv1matrixandcapsidinvolvedinresistancetoproteaseinhibitors
AT javiermartinezpicado gagproteasecoevolutionanalysesdefinenovelstructuralsurfacesinthehiv1matrixandcapsidinvolvedinresistancetoproteaseinhibitors
AT rikadraenert gagproteasecoevolutionanalysesdefinenovelstructuralsurfacesinthehiv1matrixandcapsidinvolvedinresistancetoproteaseinhibitors
AT juliagprado gagproteasecoevolutionanalysesdefinenovelstructuralsurfacesinthehiv1matrixandcapsidinvolvedinresistancetoproteaseinhibitors
_version_ 1718384560202317824